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There are several fundamental truths that those of us working at the intersection of data
science, ethics and medical research have recognised for some time. Firstly that
'anonymised’ and ‘pseudonymised' data can potentially be re-identified through the
convergence of related variables, coupled with clever inference methods (although this
is by no means easy). Secondly that genetic data is not just about individuals but also
about families and generations, past and future. Thirdly, as we enter an increasingly
digitized society where transactional, personal and behavioural data from public bodies,
businesses, social media, mobile devices and IoT are potentially linkable, the capacity
of data to tell meaningful stories about us is becoming constrained only by the questions
we ask and the tools we are able to deploy to get the answers. Some would say that
privacy is an outdated concept, and control and transparency are the new by-words.
Others either disagree or are increasingly confused and disenfranchised.
Some of the quotes from the top brass of Iceland’s DeCODE Genetics, appearing in
today’s BBC’s News, neatly illustrate why we need to remain vigilant to the ethical
dilemmas presented by the use of data sciences for personalised medicine. For those of
you who are not aware, this company has been at the centre of innovation in population
genomics since its inception in the 1990s and overcame a state outcry over privacy and
consent, which led to its temporary bankruptcy, before rising phoenix-like from the
ashes. The fact that its work has been able to continue in an era of increasing privacy
legislation and regulation shows just how far the promise of personalized medicine has
skewed the policy narrative and the business agenda in recent years. What is great about
Iceland, in terms of medical research, is that it is a relatively small country that has been
subjected to historically low levels of immigration and has a unique family naming
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system and good national record keeping, which means that the pedigree of most of its
citizens is easy to trace. This makes it an ideal Petri dish for genetic researchers. And
here’s where the rub is. In short, by fully genotyping only 10,000 people from this small
country, with its relatively stable gene pool, and integrating this with data on their
family trees - and doubtless a whole heap of questionnaires and medical records - the
company has, with the consent of a few, effectively seized the data of the "entire
population". The reference to "these tricks" by the CEO in this interview pretty much
sums it up and gives rise to a feeling of deep unease on the part of this reader. Of
course, one can't rule out some mischief making by the BBC in including these quotes -
the robustness of the science is demonstrated by its publication in the prestigious Nature
Genetics and its potential value for personalised and preventive medicine cannot be
disputed. This is important stuff for global health, and one only has to look at the media
frenzy over President Obama’s precision medicine initiative to see how much optimism
the topic is generating. However such progress demands a hand-in-glove relationship
with citizens and utter transparency of purpose. Dropping the societal and privacy
implications into the narrative only after the work has taken place is disingenuous in
the extreme. We must be careful not to make the same mistakes ourselves and we are
doing our best to engage the public in shaping the governance of the UK’s national
medical and administrative data research enterprises, constantly balancing the need for
science against the need for public trustworthiness and assent, mindful of the challenges
involved. www.adrn.ac.uk; www.farrinstitute.org
My red flags were raised closer to home this month at a promotional event for a Scottish
project which is seeking to pre-consent members of the public into data sharing for
medical research. Some of this is fairly non-contentious; it makes sense to skip a time-
consuming research stage by having a representative population of medical records to
access when seeking eligible patients for new studies, and engaging people as partners
in research must be a good thing. However a request for people's "spare blood" has
unexpectedly worked its way into the recruitment drive, with a somewhat ambiguous
message implying that blood is merely a waste product and emphasizing that no effort is
required to donate it apart from a signature. In fact the researchers are planning to
hoover up some of our most valuable data assets in the form of our genes and then reuse
them for as-yet unspecified research. Concern has been noted and should hopefully lead
to a more balanced set of messages. http://www.registerforshare.org/index.php
This sort of thing is going on worldwide, often in countries where information
governance policies and penalties for data misuse are weak or non-existent, while the
lines between identifiable vs. non-identifiable, and public vs. commercial interest are
continually blurring. Becoming attuned to public sensitivities and engaging citizens and
patients is vital for keeping a clean house and preventing potential Snowdenesque
trouble later on.
It is not insignificant that DeCODE Genetics now belongs to a Chinese company.
http://en.wikipedia.org/wiki/DeCODE_genetics I shall leave it to others to dissect the
power implications of this, and will not pre-judge the views of the Icelandic population,
whose social contract with the researchers is not clear. Perhaps others will enlighten me.
Either way it’s worth an open debate.
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